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ABSTRACT
IRF3, IRF5 and IRF9 are transcription factors, which
play distinct roles in the regulation of antiviral and
inflammatory responses. The determinants that me-
diate IRF-specific enhancer selection are not fully
understood. To uncover regions occupied predom-
inantly by IRF3, IRF5 or IRF9, we performed ChIP-
seq experiments in activated murine dendritic cells.
The identified regions were analysed with respect
to the enrichment of DNA motifs, the interferon-
stimulated response element (ISRE) and ISRE half-
site variants, and chromatin accessibility. Using a
machine learning method, we investigated the pre-
dictability of IRF-dominance. We found that IRF5-
dominant regions differed fundamentally from the
IRF3- and IRF9-dominant regions: ISREs were rare,
while the NFKB motif and special ISRE half-sites,
such as 5′-GAGA-3′ and 5′-GACA-3′, were enriched.
IRF3- and IRF9-dominant regions were characterized
by the enriched ISRE motif and lower frequency of ac-
cessible chromatin. Enrichment analysis and the ma-
chine learning method uncovered the features that
favour IRF3 or IRF9 dominancy (e.g. a tripartite form
of ISRE and motifs for NF-B for IRF3, and the GAS
motif and certain ISRE variants for IRF9). This study
contributes to our understanding of how IRF mem-
bers, which bind overlapping sets of DNA sequences,
can initiate signal-dependent responses without ac-
tivating superfluous or harmful programmes.
INTRODUCTION
The interferon regulatory factor (IRF) family is comprised
of nine members (IRF1–IRF9) in mammals (1). IRFs play
important roles, not only in interferon (IFN) induction,
but also in cell development, cell-intrinsic antiviral re-
sponses, inflammation, and oncogenesis (1,2). Within the
IRF family, IRF3, IRF5 and IRF9 have been identified
as key regulators of various antiviral and inflammatory re-
sponses (1,2). Upon stimulation by specific pathways, IRF3
and IRF5 undergo posttranslational modifications (mainly
phosphorylation), resulting in activation, nuclear translo-
cation, dimerization or complex formation (1,3). IRF3 and
IRF5 are phosphorylated by protein kinases, which are ac-
tivated by signalling pathways of pattern recognition recep-
tors (PRRs), including Toll-like receptors (TLRs) that sig-
nal via TRIF (TLR3 and TLR4) and MyD88 (e.g. TLR7
and TLR9), respectively (1,4). The binding of type I IFNs
to their receptors results in the activation of a heterotrimeric
transcriptional activator known as IFN-stimulated gene
factor 3 (ISGF3), which consists of IRF9 and signal trans-
ducer and activator of transcription 1 (STAT1) and STAT2
(1,5). In addition to the canonical ISGF3, complexes con-
taining IRF9 and either STAT1 or STAT2, but not both,
also control gene expression (6,7). Notably, the IRF associ-
ation domain (IAD) of IRF9 lacks the autoinhibitory ele-
ment, explaining previous notions that activation by signal-
induced phosphorylation may not be necessary for associ-
ation of IRF9 with STAT2 (8,9). However, an early study
suggested that IRF9 could be phosphorylated constitutively
within the DNA-binding domain (DBD) in the absence of
IFN stimuli (10).
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IRF3, IRF5 and IRF9 regulate overlapping but distinct
sets of target genes. IRF3 induces the production of many
antiviral cytokines, including IFN-, CCL5, CXCL9 and
CXCL10 (1,11,12). IRF5 is involved in inflammatory re-
sponses, as demonstrated by impaired inflammatory cy-
tokine production in Irf5-deficient mice (13,14). Besides
these prominent roles, IRF3 and IRF5 contribute to other
biological processes as well (15–18). In the ISGF3 com-
plex, IRF9 is an essential mediator of IFN signalling and
a transcriptional regulator of IFN-stimulated genes (ISG)
involved in the establishment of the so-called antiviral state
(19–21). Notably, a subset of ISGs, such as Ifit1 and Isg15,
is also regulated directly by the TLR3 pathway via IRF3
(12,22). IRFs frequently co-bind with other TFs at the pro-
moter regions or at distal enhancers of the regulated genes.
The co-binding of IRFs and members of AP-1 and NF-B
families has been well documented (23,24). Human IFNB
activation by Sendai virus infection demonstrates the cen-
tral role of co-operative binding and synergy between NF-
B, IRF3/IRF7 and ATF-2/c-Jun in selective transcrip-
tional activation (25,26). ChIP-seq analysis revealed an ex-
tensive collaboration of IRF3 and RelA in the antiviral re-
sponses (27). During viral infection, IRF3 andNF-B drive
both de novo polymerase recruitment and mediate the re-
lease of paused Pol II at their target sites (27). IRF5 bind-
ing also co-occurs frequently with RelA binding, at the
promoter of genes that are strongly induced by LPS in
macrophages (28).
Selectivity in gene activation is a well-documented phe-
nomenon for IRFs, and gene-targeting studies performed
on IRFs have revealed the markedly diverse roles played by
these transcription factors (TFs) (29). Selective gene activa-
tion is critical for limiting potential superfluous or harmful
transcriptional events. For example, after activation by in-
flammatory agents, IRF5 induces inflammatory cytokines,
without activating antiviral ISGs. Similarly, type I IFN-
activated ISGF3 establishes an antiviral state without ac-
tivating the production of type I IFNs, because this would
lead to an ‘IFN storm’ (30).
Dimers or trimers formed by IRF3, IRF5 and IRF9
regulate gene expression via indirect mechanisms or direct
DNA binding (1). The indirect mechanisms and their rela-
tive contribution to gene regulation are not completely un-
derstood. In contrast, the mechanism of direct DNA bind-
ing and IRF-bound DNA sequences have been extensively
investigated using protein bindingmicroarrays (PBM), elec-
trophoretic mobility shift assays (EMSA), and protein crys-
tallization methods (26,31–33). DNA motifs, which are en-
riched in the binding regions, have been identified by ChIP-
seq for many IRFs (11,27,28,34,35). The canonical binding
sequence for IRF dimers is called the interferon-stimulated
response element (ISRE, 5′-GAAANNGAAA-3′) (29,36–
38). ISREs are occupied by IRF homo- or heterodimers, or
by the ISGF3 complex, while a single molecule of IRF3,
IRF5 and IRF9 binds to the ISRE half-site (5′-GAAA-3′).
Many DNA sequences have been identified, which are
bound more efficiently by one IRF than another. Bases,
which have been associated with IRF-specific binding, are
localized in the 4-bp ISRE half-sites, in the 2-bp spacer be-
tween half-sites, or in the 5′ and 3′ flanking regions (31–
33). The existence of shared and IRF-specific binding se-
quences provides a potentialmechanism for the IRFs to reg-
ulate both common and dimer-specific genes (33). However,
the contribution of these sequences to IRF-specific bind-
ing has not been evaluated by genome-wide ChIP-seq stud-
ies. In the current study, our starting assumption was that
DNA sequences that play a role in enhancer selection by
these IRFs and their dimerization and trimerization part-
ners are enriched in the binding regions occupied domi-
nantly by IRF3, IRF5 or IRF9. We also postulated that if
chromatin accessibility and collaborating TFs contribute to
IRF-specific binding, the binding regions would differ from
each other in terms of chromatin status and the presence
of co-binding TF DNA motifs. To test these hypotheses
and to determine which features contribute to IRF-specific
binding, we identified and characterized binding regions for
IRF3, IRF5 and IRF9 in stimulated dendritic cells (DCs).
Our analysis indicates that IRF-specificity in enhancer se-
lection is mediated by DNA sequences occupied directly by
IRFs, and additional features in a combinatorial fashion.
MATERIALS AND METHODS
Cells and ligands
A wild-type CD8+ dendritic cell line (MuTu1940) was es-
tablished and cultured as described previously (22,39). For
ChIP-seq and ChIP-qPCR experiments, CD8+ dendritic
cells (DCs) were treated for 90 min with 5 g/ml of high
molecular weight polyinosinic–polycytidylic acid (pIC, In-
vivoGen), 1 mM class B CpG oligonucleotide 1826 (CpG,
InvivoGen) or 100U/ml interferon- (IFN-,Millipore) or
a combination of these ligands. The binding sites of IRF3,
IRF5 and IRF9were determined inDCs stimulated by pIC,
CpG and IFN-, respectively. The binding of cRel and Junb
was determined in CpG-stimulated and unstimulated DCs.
For gene expression qPCR experiments, CD8+ DCs were
treated for 1.5, 3, 6 or 12 h with 5 g/ml pIC, 1 mM CpG
or 100 U/ml IFN-.
ChIP-seq and ChIP-qPCR
Chromatin immunoprecipitation coupled with high-
throughput sequencing (ChIP-seq) experiments were
performed as previously described (40–42) with minor
modifications. Briefly, 10–20 million DCs were crosslinked
with 2 mM disuccinimidyl glutarate (DSG, ProteoChem)
for 40 min and 1% methanol-free formaldehyde (Thermo
Fisher Scientific) for 10 min. Cross-linking was stopped by
the addition of glycine to a final concentration of 0.125
M for 10 min followed by addition of ChIP lysis buffer
containing 150 mM NaCl, 1 mM EDTA pH 8, 20 mM
Tris–HCl pH 8, 1% Triton X-100, 0.1% SDS with protease
inhibitors (cOmplete Mini EDTA-free protease inhibitor
cocktail, Roche). Chromatin was sheared with sonication
(Diagenode Bioruptor Standard) and immunoprecipitated
overnight using antibodies against IRF3 (D83B9, Cell
Signaling), IRF5 (ab21689, Abcam), IRF9 (AF5629, R&D
Systems), cRel (sc-71x, Santa Cruz Biotechnology) and
Junb (sc-46x, Santa Cruz Biotechnology). Chromatin-
antibody complexes were washed and eluted after being
pulled down with magnetic beads (Protein A or G Dyn-
abeads, Thermo Fisher Scientific). Eluted complexes were
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de-crosslinked overnight and purified using a NucleoSpin
Gel and PCRClean-up Kit (Macherey-Nagel). ChIP-DNA
was quantified using a Qubit fluorometer. For ChIP-seq
experiments indexed cDNA libraries were prepared from
1 to 10 ng ChIP-DNA using a TruSeq ChIP Sample
Preparation Kit (Illumina) according to manufacturer’s in-
structions. Libraries were sequenced on Illumina NextSeq
500 or HiSeq 2500 platforms. For ChIP-qPCR experiments
primers were designed for amplifying the promoter regions
of the nine paradigm genes and enrichment was determined
by qPCR relative to input using the ready-to-use hot start
reaction mix, LightCycler 480 SYBR Green I Master
(Roche) and the LightCycler 480 Instrument (Roche).
Primer sequences are available in Supplementary Table S4.
ChIP-seq data analysis
The primary analysis of raw ChIP-seq reads was carried out
using our ChIP-seq analysis pipeline (43). Briefly, Burrows-
Wheeler Alignment Tool (bwa, (44)) was used to align the
reads with the mm10 genome assembly, and Model-based
Analysis of ChIP-Seq 2 (MACS2, (45)) was used for pre-
dicting peaks (binding regions) with the following specific
parameters: qvalue cut-off (q) = 0.001 and subpeaks de-
convolved within each peak (–call-summits). Artifacts were
removed using the ENCODE blacklist (46). The identified
peak summits were extended by ±100 bp to obtain binding
regions. Consensus peak sets for each IRF contain the com-
mon peaks of the duplicates. By merging binding regions
of IRF3, IRF5 and IRF9, a ‘unified IRF3/IRF5/IRF9
cistrome’ was generated. Coverage of predicted peaks (ex-
pressed as Reads Per Kilobase Million, RPKM) was cal-
culated using bamtools, bedtools (coverageBed), and awk.
For clustering, occupancy values were normalized by the
median of values of each IRF. Integrative Genomics Viewer
(IGV, Broad Institute) was used for data browsing and cre-
ating representative snapshots (47). Genome coverage files
(BedGraphs) were converted into tdf files using igvtools
with the ‘toTDF’ option. Normalized tag counts for read
distribution (RD) histograms and heatmapswere generated
byHOMER (48) and then visualized byRor Java TreeView.
IDR analysis
Irreproducible Discovery Rate (IDR) analysis (49) was used
to quantify the consistency between replicates. The software
(https://github.com/nboley/idr) uses the narrowPeak files
of MACS2 peak calling, calculates a q-value for each peak
of the two datasets, and gives a cutoff value for separating
low confidence regions from high confidence regions.
De novo motif discovery, PWM enrichment analysis, and the
search for DNA sequences
200 bp long regions were used for motif enrichment anal-
yses, performed by findMotifsGenome.pl (HOMER). P-
values were calculated by comparing the target region en-
richments with those of background sets generated by
HOMER. Position weight matrices (PWMs) for ISRE,
EICE, AICE1, NFKB, TRE, CRE and GAS motifs were
obtained from the HOMER database (Supplementary Ta-
ble S2). PWMs for IECS,AICE2 andTISREwere not avail-
able in the database; therefore, PWMs were generated by
re-analyzing publicly available ChIP-seq datasets (Supple-
mentary Table S2). The threshold values (cut-offs) for each
motif were determined based on a set of randomly selected,
size-matched genomic regions (random set). The 95th per-
centile value of each motif was used as a cut-off. Map-
ping of PWMs in the genome was performed by scanMo-
tifGenomeWide.pl (HOMER). Calculation of motif scores
in IRF binding regions was performed by annotatePeaks.pl
(HOMER). For searching special DNA sequences in the
clusters, lists of 6-mers and ISRE variants were generated.
The DNA sequence of each binding region was obtained
from the mouse genome (GRCm38/mm10) using bedtools
(fastaFromBed). Using grep command, we searched for all
6-mers and ISRE variants and their reverse complements in
all binding regions. The position of the GAANNGAAA se-
quence was determined genome-wide using the R package
Biostrings.
ATAC-seq experiments and data analysis
Assay for Transposase Accessible Chromatin (ATAC) with
high-throughput sequencing (ATAC-seq) was carried out in
biological duplicates as described earlier with minor modi-
fications (50). Cells were scraped and counted to achieve 10
000–15 000/ml in ice-cold PBS. Nuclei were isolated with
ATAC lysis buffer (10 mM Tris–HCl pH 7.4, 10 mMNaCl,
3 mM MgCl2 and 0.1% IGEPAL). Nuclei were used for
tagmentation from two biological replicates using a Nex-
tera DNA Library Preparation Kit (Illumina). After tag-
mentation, DNA was purified with a MinElute PCR Pu-
rification Kit (QIAGEN). Tagmented DNA was amplified
with Kapa Hifi Hot Start Kit (Kapa Biosystems) using
nine PCR cycles. Amplified libraries were purified again
with MinElute PCR Purification Kit. Fragment distribu-
tion of libraries was assessed with Agilent Bioanalyzer and
libraries were sequenced on an Illumina HiSeq 2500 plat-
form. Similarly to ChIP-seq analysis, primary analysis of
the ATAC-seq raw reads was carried out using an analysis
command line pipeline. Briefly, bwa was used to align the
reads with the mm10 genome assembly using default pa-
rameters and MACS2 was used for predicting ATAC-seq
peaks (q-value ≤ 0.001). Artifacts were removed using the
ENCODE blacklist. Genome coverage files (BedGraphs)
for visualization purposes were generatedwithmakeUCSC-
file.pl and then converted into tdf files using igvtools with
the ‘toTDF’ option. IGV was used for data browsing and
creating representative snapshots. For calculating the ra-
tio of ATAC-positive regions, the overlap between the IRF
binding regions andATAC-seq peaks was determined using
‘bedtools intersect’. For the identification of ATAC-positive
IRF-binding regions by ‘bedtools intersect’, we used the
ATAC sample, which contained more identified ATAC-seq
peaks.
Ternary diagrams
An R software package, ‘ggtern’, was used to create the
ternary diagrams that show the ratios between the three
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variables (median normalized IRF3, IRF5 and IRF9 occu-
pancy values). A given point on the ternary diagram repre-
sents one binding region, and the three input variables for a
given point are the median-normalized occupancy values of
the IRFs in the given region. Colour gradients for NFKB,
TRE, CRE, GAS and ATAC are based on motif similarity
scores or RPKM values.
PCA and machine learning
For Principal Component Analysis (PCA), the scikit-learn
Python library was used, and two principal components
were computed. The input for the PCA was a table con-
taining the three IRFs’ occupancy values and enhancer fea-
tures per peak. PCA was run on the three IRFs’ occupancy
values for one plot, and on 11 enhancer features for the
other. PCAwas visualized withmatplotlib, a Python library
for 2D plotting. The Random Forest machine learning
method was applied in Python using the RandomForest-
Classifier from the scikit-learn package. The motif scores
for ten PWMs, ATAC-seq signals, and occurrence data con-
cerning 37 variants of ISRE and 30 selected 6-mers were
used as attributes of the binding regions. Various sets of
these values were used as input variables for Random For-
est, while cluster names were used as ‘class labels’. The Ran-
dom Forest method not only provided prediction accuracy,
but also reported the relative importance of the features
(‘feature importance’ or ‘predictive power’). For selecting
6-mers with high predictive power, we performed nine Ran-
dom Forest classification using the occurrence data of all
6-mers (n = 535) and running three analyses for each com-
parison (TLR3-dom. versus TLR5-dom., TLR3-dom. ver-
sus TLR9-dom. and TLR5-dom. versus TLR9-dom). The
6-mers were ranked based on their cumulative importance
scores calculated from the nine scores. Based on additional
test runs, we decided to use the ‘Top 30’ 6-mers, because ac-
curacies were not increased significantly, when more than
thirty 6-mers were used for the predictions.
ROC curves and AUC values
Receiver operating characteristic (ROC) curve analysis was
used to evaluate the ability of different motifs to separate
two datasets with the Random Forest classifier algorithm.
The algorithm performed binary classification using the
IRF dominant and IRF cistrome datasets pairwise, with
the given motifs scores as its input features. The dataset was
split into training and test sets. The analysis uses the scikit-
learn Python library for both running the machine learning
algorithm and calculating and visualizing the ROC curve
and Area Under Curve (AUC) value. The classifier gives a
probability estimate for both of the class labels, which shows
what the probability of a given record from the test set is in
that class. TheROC curve shows how the classifiers perform
with different cutoff values of the prediction probabilities.
The AUC measures the area under the ROC curve.
Gene sets
Genes belonging to various GO categories were down-
loaded from the Mouse Genome Informatics (MGI)
database (http://www.informatics.jax.org). The list of ‘an-
tiviral cytokines’ contains the common genes of ‘defence
response to virus‘ (GO:0051607) and ‘cytokine activity’
(GO:0005125) GO categories. The list of ‘inflammatory
program’ contains those genes of ‘inflammatory response‘
(GO:0006954), which were also listed in the ‘cytokine ac-
tivity’ (GO:0005125) or ‘DNA-binding transcription fac-
tor activity‘ (GO:0003700) categories. The list of ‘antiviral
ISGs’ was selected based on review articles on ISGs (20,21).
Gene lists are supplied in the Supplementary Table S3.
Quantitative PCR (qPCR)
RNAwas isolated using Trizolate reagent (UD-GenoMed).
Reverse transcription was performed using a High Capac-
ity cDNA Reverse Transcription Kit (Thermo Fischer Sci-
entific) according to the manufacturer’s instructions. Quan-
titative PCR (qPCR) was performed using the ready-to-use
hot start reactionmix, LightCycler 480 SYBRGreen IMas-
ter (Roche) and the LightCycler 480 Instrument (Roche).
The comparative cycle threshold method was used to calcu-
late expression relative to Rplp0. Primer sequences are sup-
plied in Supplementary Table S4.
RESULTS
Clustering IRF3, IRF5 and IRF9 binding regions
We utilized a transformed murine DC line that ex-
hibits most features of primary CD8+ DCs (22,39), but
provides a significantly greater number of cells. IRF3,
IRF5 and IRF9 are highly expressed at the protein and
mRNA levels in this DC subset (Supplementary Fig-
ure S1A). To map IRF3, IRF5 and IRF9 binding re-
gions, we performed ChIP-seq analyses after stimulat-
ing DCs for 90 minutes with polyinosinic-polycytidylic
acid (pIC), synthetic oligodeoxynucleotides containing
CpG motifs (CpG) or IFN-, respectively. These lig-
ands activate receptors, signalling pathways, and the cor-
responding IRFs very efficiently (e.g. pIC→TLR3→IRF3,
CpG→TLR9→IRF5 and IFN-→IFNAR1/2→IRF9).
ChIP-seq experiments were performed with biological du-
plicates (SupplementaryFigure S1B), resulting in the identi-
fication of 25 203, 17 435 and 25 040 peaks (binding regions)
for IRF3, IRF5 and IRF9, respectively. We performed an
IDR analysis (49) of the IRF ChIP-seq data sets (the re-
sults are shown in Supplementary Table S1). The compar-
ison of our results with publicly available IRF3 and IRF5
ChIP-seq data sets (Supplementary Table S5, (11,28,34,51))
are shown in Supplementary Figure S1C.
After mapping binding regions for IRF3, IRF5 and
IRF9, we determined the regions, which were differently
bound by these IRFs. We generated a complete list of
genomic regions (hereafter, referred to as the ‘unified
IRF3/5/9 cistrome’) that were bound by at least one IRF
(Figure 1A). We calculated the normalized occupancy val-
ues for IRF3, IRF5 and IRF9 and determined the ratio of
occupancy values. A genomic region was considered IRF3-
, IRF5- or IRF9-dominant if the normalized occupancy
value of the corresponding IRF was at least twofold higher
than the values for the other two IRFs (Figure 1B). If the
occupancy values for IRF3, IRF5 and IRF9 on a given
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Figure 1. Identification of binding regions occupied differently by IRF3, IRF5 and IRF9. (A) Read distribution plot of IRF3, IRF5 and IRF9 in a 2
kb window around the summit of the IRF peaks. For ChIP-seq experiments, murine CD8+ DCs were treated for 90 min with high molecular weight
polyinosinic-polycytidylic acid (pIC), class B CpG oligonucleotide (CpG) or interferon- (IFN-). The binding sites of IRF3, IRF5 and IRF9 were
determined in DCs stimulated for 90 minutes by pIC, CpG, and IFN-, respectively. (B) The distribution of binding regions occupied by IRF3, IRF5 and
IRF9 is shown on a ternary plot. The position of each dot in the interior of the triangle was calculated based on the normalized IRF3, IRF5 and IRF9
occupancy values. The seven IRF-binding clusters were classified based on the fold induction values. The normalized occupancy values in the dominant
clusters exhibit at least two-fold differences relative to the two other IRFs. (C) The genome browser view of IRF3, IRF5 and IRF9 peaks in the 40 kb
window around the TSS of three representative genes. Arrowheads indicate binding regions occupied in an IRF3-dominant (red), IRF5-dominant (blue) or
IRF9-dominant (green) manner.
binding regions were similar (0.5 < ratio < 2), the region
was considered to be a common binding region for IRF3,
IRF5 and IRF9 (referred to as a ‘Common cluster’). We
also determined three additional clusters (Shared clusters),
in which the binding by one IRF was weaker than the other
two IRFs (binding regions shared by ‘IRF3 and IRF5’,
‘IRF3 and IRF9’ and ‘IRF5 and IRF9’). Collectively, the
unified IRF3/5/9 cistrome was classified into seven clus-
ters based on IRF binding patterns (Figure 1A and B).
IRF3-, IRF5- and IRF9-dominant binding regions are ex-
emplified in Figure 1C by the cis-regulatory elements of
Ifnb1, Il12b and Eif2ak2. These genes have been identi-
fied as IRF3, IRF5 and IRF9 target genes, respectively
(18,26,52).
Identification of DNA motifs in the IRF3-, IRF5- and IRF9-
dominant clusters
We analysed DNA motifs and sequences in the IRF3-,
IRF5- and IRF9-dominant clusters using three different
strategies: (i) de novomotif discovery, (ii) enrichment analy-
sis of position weight matrices (PWMs) and (iii) a search for
specific DNA sequences (Figure 2A). The three strategies
have their own advantages and limitations and combining
these approaches resulted in a more complex picture. For
the sake of simplicity, we focused on the genomic regions,
which were occupied dominantly by one of the three IRFs
(e.g. IRF3-, IRF5- and IRF9-dominant clusters). However,
we performed similar analyses for the three Shared and the
Common clusters aswell as for the entire IRF3, IRF5, IRF9
cistromes. The key results for these analyses are provided as
supplementary data (Supplementary Figure S2).
Using the first approach (de novo motif discovery), we
found that themost enrichedmotifs in the IRF3- and IRF9-
dominant clusters were DNA motifs that resembled ISRE,
or a ‘mixture’ of ISRE and an Ets-IRF composite ele-
ment (EICE) (53,54) (Figure 2B). Consistent with previ-
ous IRF5ChIP-seq studies (28,34,55), de novomotif discov-
ery failed to detect an ISRE motif in the IRF5-dominant
cluster. However, an ISRE half-site motif and a weak IRF-
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Figure 2. DNA motifs and sequences in the IRF-binding clusters. (A) A scheme showing the three different strategies for identification of DNA motifs
and sequences in the clusters. Position weight matrices, PWMs. (B) Results of de novomotif discovery from the IRF3-, IRF5- and IRF9-dominant clusters.
Motif frequencies (%) in the target (tg) and background set (bg) are shown. (C, D) PWM enrichment analysis in three IRF clusters. The enrichment was
calculated relative to the random set. PWMs were obtained from the HOMER database or from re-analysed ChIP-seq datasets. (C) The enrichment of six
PWMs for IRF-binding DNA sequences and (D) four PWMs for co-activated transcription factors are shown. (E) The distribution of NFKB, TRE, CRE
and GAS motifs is shown on ternary plots. The position of each dot in the interior of the triangle was calculated based on the normalized IRF3, IRF5 and
IRF9 occupancy values, while colours indicate motif scores. IRF binding regions with motif scores above the cut-offs are shown.
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Ets composite sequence (IECS) (56), were enriched in this
cluster (Figure 2B). In addition to these IRF-binding mo-
tifs, several other motifs were identified, including the NF-
B-binding motif (B or NFKB), the TPA response ele-
ment (TRE), the cAMP response elements (CRE) and the
gamma IFNactivation site (GAS). Thesemotifs are binding
sites for TFs that are co-activated with IRFs in a pathway-
specific manner. Upon TLR ligation, IRF3 or IRF5 are ac-
tivated together with activating protein 1 (AP-1) members,
which bind TRE or CRE (57), and members of the NF-
B family, which bind to B sites (58). I-IFNs induce the
formation of the ISGF3 complex together with STAT1 ho-
modimers, which bind to GAS (59–61). The results of the
de novo motif discovery for the other clusters, and for the
entire IRF3, IRF5 and IRF9 cistromes are shown in Sup-
plementary Figure S2A, B.
Due to the limitation of the de novo motif discovery
method, similar motifs could be merged, eliminated, or un-
derestimated. Moreover, a direct comparison of motif en-
richment in different clusters is not feasible. Our second
approach compared the enrichment of the same PWMs
in the clusters side-by-side. We obtained PWMs from the
HOMER database or from reanalysed ChIP-seq data (Sup-
plementary Table S2). In addition to ISRE, EICE, IECS
and the motifs for co-activated TFs, we investigated three
longer motifs. Two composite elements for AP-1 and IRF
(AICE1 and AICE2) were identified as binding sites for
IRF4 and/or IRF8 and their co-binding TFs (62–66).
A tripartite form of ISRE (called hereafter as ‘TISRE’),
which was previously identified as binding sites for IRF1,
IRF2 and IRF8 (35,38,67) was also included in the anal-
ysis. We determined the threshold (cut-off) values for each
motif systematically, based on a set of randomly selected
size-matched genomic regions (random set) (Supplemen-
tary Figure S2C). We then calculated the PWM enrichment
relative to the random set (Figure 2C and D). We made the
following four observations. First, as expected, ISRE was
the most enriched motif in the IRF3- and IRF9-dominant
cluster, while it was poorly enriched in the IRF5-dominant
cluster (Figure 2C). Second, TISRE was especially frequent
in the IRF3-dominant cluster. Third, the enrichment of the
EICE motif was similar to the ISREs’ in the investigated
clusters. These results do not imply necessarily that IRF3-
dimers and ISGF3 (STAT1/STAT2/IRF9) bind EICE mo-
tif with a high frequency. More likely, IRF3-dimers and
ISGF3 show a preference for accessible genomic regions
that are primed by PU.1 and IRF8. These two TFs are
lineage-determining TFs in this DC subtype (68), and to-
gether they bind EICE and IECS (56). Last, de novo motif
discovery results and the enrichment analysis of PWMs for
co-activated TFs agreed in most cases. Most co-activated
TF motifs, which were detected with the low p-value by the
de novo motif discovery, were enriched in the IRF domi-
nant clusters; NFKB, TRE, and CRE motifs in the IRF3-
dominant cluster,NFKB in the IRF5-dominant cluster, and
GAS in the IRF9-dominant cluster (Figure 2D). The only
discrepancy was observed in the IRF5-dominant cluster,
where TRE and CRE motifs were enriched by de novo mo-
tif discovery, but not by PWM analysis. The differences in
the enrichments are coming from the fact that de novo de-
termined PWMs are similar but not identical to the PWMs
obtained from the HOMER database (Figure 2B and D),
and only de novo determined PWMs were enriched. We also
investigated the distribution of binding regions, which con-
tained sequences with high motif scores for co-activated
TFs (Figure 2E). Since motif scores signify similarities be-
tween the identified DNA sequences and the used PWMs,
these sites typically represent high affinity binding sites. We
found that NFKBmotifs with high scores were polarized in
the IRF3- and IRF5-dominant clusters, while regions con-
tainingGASmotifs with high scores were specially enriched
in the IRF9-dominant cluster. In the case of TRE and CRE
motifs, a modest IRF3- and IRF5-biased polarization was
detectable. PWM enrichment analysis for the other four
clusters is shown in Supplementary Figure S2D. Previous
studies demonstrated that many genes are co-regulated by
I-IFN and NF-B pathways (69,70). The low frequency of
the NFKB motif in the IRF9-dominant cluster raised the
question of what types of binding regions could be respon-
sible for the cross-talk between I-IFNandNF-Bpathways.
By analysing the frequency of NFKB motifs in the clus-
ters (Supplementary Figure S2D) and the binding regions
associated with genes co-regulated by I-IFN and NF-B
pathways, we concluded that binding regions occupied by
IRF3, IRF5 and IRF9 (Common Cluster) play a promi-
nent role in the cross-talk. (The list of co-regulated genes
by I-IFNandNF-Bpathwayswas obtained from the study
of Wienerroither et al. (69). Illustrative binding regions co-
occupied by IRF9 and cRel associated with co-regulated
genes are shown in Supplementary Figure S2E.)
Variants of ISRE and ISRE half-sites in the IRF3-, IRF5-
and IRF9-dominant clusters
Using our third approach (search for specific DNA se-
quences), we were able to discriminate similar DNA se-
quences and determine their enrichments separately. We
searched for 6-mers and ISRE variants that were distributed
differently among the clusters. We investigated 6-mers in-
stead of 4-mers because IRF binding is affected by 5′ and
3′ flanking bases of the 4bp long ISRE half-sites (31). We
generated a list of all 6-mers, which contained the canoni-
cal 5′-GAAA-3′ and two extra bases (5′-NNGAAA-3′, 5′-
NGAAAN-3′ or 5′-GAAANN-3′). In the 5′-GAAA-3′ se-
quence, one mismatch was allowed (Supplementary Table
S6). We determined the frequency of these 6-mers (n= 535)
in the clusters (Figure 3A). We identified 6, 68 and 10 se-
quences that occurred at least 1.5 times more frequently in
the IRF3-, IRF5 and IRF9-dominant clusters, respectively,
compared to the other two clusters (Supplementary Table
S6 and Figure S3A). Notably, the enrichment of many 6-
mers was consistent with the results of the previous in vitro
studies. PBM data indicated that sequences that contain 5′-
GGAAAC-3′ are bound with higher affinity by IRF3 com-
pared to IRF5, IRF6 or IRF9 (31,33). Consistent with this
observation, we found that GGAAAC is more enriched in
the IRF3-dominant cluster (first plot onFigure 3B and Sup-
plementary Figure S3A). PBM experiments revealed that
IRF5 is more tolerant of the ISRE half-site at position 3
and 4 (5′-GAAA-3′) than IRF7 (33) or certain other IRFs
(31). We detected enrichment of several 6-mers that differed
at these positions from the canonical 5′-NGAAAN-3′ core
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Figure 3. Frequency and distribution of extended ISRE half-sites (6-mers) and ISRE variants in the IRF-binding clusters. (A) The frequency of 6-mers
in IRF-binding clusters is shown on a heat map. (B) The distribution of binding regions containing the indicated 6-mers is shown on ternary plots. (C)
The frequency of ISRE variants in IRF-binding clusters is shown on a heat map. (D) The distribution of binding regions containing the indicated ISRE
variants is shown on ternary plots. On panel B and D the position of each dot in the interior of the triangle was calculated based on the normalized IRF3,
IRF5, and IRF9 occupancy values. (E) A heat map showing the frequency of selected 6-mers (n = 13), which were more frequent in the IRF5-dominant
cluster, than in the IRF3-, or IRF9-dominant clusters. (F) ROC curves and AUC values as determined in the indicated pair-wise comparisons. Occurrence
data of 13 selected 6-mers, which were most frequent in the IRF5-dominant cluster, were used as input features for the analyses. TPR, true positive rate;
FPR, false positive rate.
sequence (for example, CGACAC, CGAGAC, CGAACC
and CGAAGC) in the IRF5-dominant cluster (second and
third ternary plots on Figure 3B, and Supplementary Fig-
ure S3A). Finally, in PBM experiments, TGAAAC was
bound with higher affinity by IRF9 compared to IRF3,
IRF5 or IRF6 (31). This and some other 6-mers, such as
GAAACT, were especially enriched in the IRF9-dominant
clusters (fourth plot on Figure 3B, and Supplementary Fig-
ure S3A).
We also searched for specific ISRE variants (n = 37) that
were selected based on previous studies (31–33,38) or
our 6-mer analysis (Figure 3C, D, Supplementary Fig-
ure S3B and Table S6). We identified 20 and 4 ISRE
variants that occurred at least 1.5 times more frequently
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in the IRF3- and IRF9-dominant clusters, respectively,
compared to the other two clusters. We could not de-
tect any ISRE variants, which occurred more frequently
in the IRF5-dominant cluster than in the other two
clusters.
Consistent with the 6-mer results, we found that
GGAAANNGAAAoccurredmore frequently in the IRF3-
dominant cluster relative to the other clusters (first plot on
Figure 3D). This sequence has been identified as the EIRE
motif (3,71). The ISREs in which half-sites were separated
by a 3 bp spacer, and ISREs with two extra AA at the 5′
position, also occurred more frequently in this cluster (Sup-
plementary Figure S3B and second plot on Figure 3D).
Notably, ISRE variants (e.g. 5′-GAAANNGAGA-3′ and
5′-GAGANNGAGA-3′), which contained ISRE half-sites
preferentially bound by IRF5 (e.g. GAGA) did not oc-
cur more frequently in the IRF5-dominant cluster (third
ternary plot on Figure 3D and Supplementary Figure S3B).
EMSA and protein crystallization experiments suggest
that, due to additional contacts between DNA and STATs,
the ISGF3 complex has sequence requirements that extend
beyond the consensus ISRE motif (8,32) and the detailed
consensus for ISGF3 is 5′-WBVGGAAANNGAAACT-
3′ (W = A or T; B = C or G or T; V = A or C or
G). Of note, the special sequence requirement for ISGF3
does not necessarily imply that these sequences are bound
more efficiently by IRF9 than other IRFs. Notably, we
found that 5′-GAAANNGAAACT-3′ (fourth on Figure
3D), but not GGAAANNGAAA (first plot on Figure 3D)
or WBVNGAAANNGAAA (Supplementary Table S6),
were enriched in the IRF9-dominant cluster. The binding
regions with the entire detailed consensus for ISGF3 (5′-
WBVGGAAANNGAAACT-3′) were also enriched, but
less than 1% (55 out of 7373) of IRF9-dominant binding
regions (Supplementary Figure S3B) contained these ISRE
variants.
ROC (Receiver Operating Characteristics) analysis is fre-
quently used for assessing a classification model’s perfor-
mance (72). We determined ROC curves, and calculated
AUC (Area Under the Curve) values in pair-wise compar-
isons for the three IRF-dominant subsets and three IRF
cistromes. The following three types of input features were
used: (i) motif strength of the ISRE motif (similarity score
for the ISRE PWM from HOMER database), (ii) occur-
rence data of selected 6-mers (n = 13), which were most
frequent in the IRF5-dominant cluster and (iii) occurrence
data of selected ISRE variants (n = 7), which were most
frequent in the IRF3-dominant cluster (Figure 3E, F and
Supplementary Figure S3C, D). Because AUC represents
the degree or measure of separability, the higher the AUC,
the better the machine learning model is at predicting the
class label in pair-wise comparisons. We found that ISRE
motif scores could not separate IRF3-dominant vs. IRF9-
dominant clusters or IRF3 versus IRF9 cistromes (low
AUC values). In contrast, ISRE motif scores could sep-
arate IRF5-dominant and IRF5 cistrome from the other
clusters/cistromes (higherAUCvalues, Supplementary Fig-
ure S3C). These data are consistent with the enrichment
analyses: the frequency of ISRE is higher in the IRF3- and
IRF9- dominant clusters, and IRF3 and IRF9 cistromes
compared to the IRF5-dominant cluster and the IRF5
cistrome. As expected, the occurrence data of 6-mers most
frequent in the IRF5-dominant cluster could not separate
IRF3-dominant vs. IRF9-dominant clusters and IRF3 ver-
sus IRF9 cistromes (low AUC values). In contrast, these
6-mers could separate IRF5-dominant clusters from the
other clusters (higher AUC values, Figure 3F). When oc-
currence data of selected ISRE variants (n = 7) were used
for AUC analysis for the comparison of IRF3-dominant vs.
IRF5- or IRF9-dominant clusters AUC values were higher
(0.69 and 0.63). The AUC value was lower (0.59) in the
IRF5-dominant vs. IRF9-dominant comparison. These re-
sults mirror the differences in the frequencies of these ISRE
variants (e.g. IRF3-dominant > IRF9-dominant > IRF5-
dominant cluster.
Collectively, certain 6-mers and ISRE variants were dis-
tributed differently in IRF-binding clusters; therefore, these
DNA sequences most likely contribute to IRF-specific
binding. None of the ISRE variants occurred exclusively in
IRF-specific clusters. Thus, these sequences alone could not
determine specificity.
Prior to stimulation, many IRF3- and IRF9-dominant bind-
ing regions have low accessibility
Previous studies revealed that a majority of the binding
of stimulus-regulated TFs occurs at pre-existing enhancer-
like accessible regions (73,74). A smaller percentage of TFs
bind to ‘latent’ or ‘de novo’ enhancers defined as regions
that acquire histone marks characteristic of enhancers only
after stimulation (73,74). The recruitment of co-activators
by TFs occupying pre-existing or de novo enhancers typi-
cally increases the acetylation of H3 and H4 histone tails
and/or chromatin accessibility. IRF3 can promote nucleo-
some remodelling and/or the opening of previously inac-
cessible genomic regions in LPS-stimulated macrophages
(75). Chromatin opening by ISGF3 has also recently been
studied (76,77). Au-Yeung and Horvath found that stimu-
lation with I-IFN decreased promoter-associated histones
(e.g. H2A.Z), consistent with the observed nucleosome re-
organization identified at ISG promoters. To our knowl-
edge, the ability of IRF5 to reshape the chromatin landscape
has not been investigated in genome-wide studies. Because
different signaling pathways activate both overlapping and
unique sets of ‘latent’ or ‘de novo’ enhancers (74), chro-
matin accessibility could be an important determinant for
IRF-specific enhancer selection. Therefore, we investigated
the accessible chromatin regions by performing ATAC-seq
(Assay for Transposase Accessible Chromatin with high-
throughput sequencing (50)) experiments in un-stimulated
(UT)DCs. Based on these results, we calculated the percent-
ages of accessible regions in the IRF cistromes and clusters
(Figure 4A), and we determined the position of accessible
regions relative to IRF peaks and motifs (Supplementary
Figure S4B). We also investigated the distribution of IRF-
binding regions with high ATAC-seq signals (Supplemen-
tary Figure S4C)
Regarding the cistromes, we found that the difference was
moderate (∼13%) between the lowest and highest frequen-
cies (IRF3: 56.8% versus IRF5: 69.8%). The overlap be-
tween IRF binding regions, the accessible genomic regions
and the canonical ISRE (GAAANNGAAA) sequence was
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Figure 4. Chromatin accessibility in the IRF cistromes and IRF-binding
clusters. (A) The frequency of ATAC-seq positive regions in unstimulated
(UT) DCs is shown for the IRF cistromes and IRF-binding clusters. (B)
The overlap between the canonical ISRE (GAAANNGAAA) sequence,
the accessible genomic regions in unstimulated (UT) DCs, and IRF3-
binding regions in pIC-stimulated DCs is shown on a Venn diagram. (C)
Percentages of the canonical ISRE (GAAANNGAAA) sequence and ac-
cessible genomic regions in unstimulated (UT) DCs, which were bound by
IRF3 after pIC-treatment. (D) The genome browser view of the binding of
IRF3, IRF5 and IRF9, and theATAC-seq signal. The positions ofmapped
binding regions are also shown. Two regions (nos. 1 and 4), which had low
or no accessibility prior-to-stimulation and were occupied dominantly by
IRF3 upon stimulation, are highlighted. Regions indicated with an aster-
isk (*) were not identified as IRF binding regions, most likely due to the
strict peak calling strategy.
also determined to evaluate the impact of accessibility to-
gether with a high-affinity IRF-binding motif (Figure 4B
and Supplementary Figure S4A). We found that only a mi-
nority of the canonical ISRE sequences (<1%) were occu-
pied by IRF3 upon activation in vivo. In contrast, ∼35% of
the regions, which were accessible before stimulation, were
occupied by IRF3 after stimulation (Figure 4C). Of note,
the exact ratio of accessible regions with or without any
ISREmotifs could not be determined, because the presence
of other ISRE variants was not investigated.
Regarding the IRF-binding clusters, we detected much
larger differences (∼50%) between the lowest and highest
frequencies (IRF3-dominant: 23.8% vs. Common: 73.8%).
Notably, the lowest percentages of accessible regions were
detected in the IRF3- and IRF9-dominant clusters (28.3%
and 36.6% respectively; Figure 4A). We found that the
IRF3-dominant regions, which were not accessible prior to
stimulation, were often accompanied by fully accessible en-
hancers. The diversity of binding regions is exemplified by
the cis-regulatory elements localized upstream of Ccl5 in
Figure 4D. In contrast to IRF3 and IRF9, we found that
the percentage of accessible regions was relatively high in
the IRF5-dominant cluster (62.4%).
Collectively, these observations suggest that chromatin
accessibility is a critical determinant for all the investigated
IRFs. A majority of the IRF3, IRF5 and IRF9 binding
events occurs at pre-existing accessible regulatory regions.
Our data suggest that IRF3 and IRF9 (in the ISGF3 com-
plex) more frequently occupy ‘latent’ or ‘de novo’ enhancers
than IRF5. Notably, the finding that ATAC-negative re-
gions were especially enriched in the IRF3- and IRF9-
dominant regions suggests that the ‘chromatin barrier’ con-
tributed to IRF3- and IRF9-specific, but not to IRF5-
specific, enhancer selection, by inhibiting the binding of
other IRFs. Our observations are consistent with previous
findings related to other TFs indicating that chromatin fea-
tures play active roles in shaping the selective transcrip-
tional responses (78).
Machine learning predictions of IRF dominance
To investigate the relationship between enhancer features
and IRF dominance, we used two approaches: a princi-
pal component analysis (PCA) and a machine learning ap-
proach called Random Forest (79,80). As expected, the
three clusters were completely separated by PCA when
IRF3, IRF5 and IRF9 occupancy values were used as input
variables (Figure 5A, left panel). Using 10 motif scores and
ATAC signals as inputs for PCA, the separation was not
complete.Most binding regions in the IRF5-dominant clus-
ter were separated from the binding regions in the IRF3-
and IRF9-dominant clusters. In contrast, IRF3 and IRF9-
dominant clusters appeared as partially overlapping popu-
lations (Figure 5A, right panel).
After PCA, we used RandomForest, which combines the
predictions of simple decision trees using a voting system.
One of the most common applications of machine learn-
ing methods is to predict the ‘class label’ of any given en-
tity after a learning phase based on several attributes. Using
Random Forest, we investigated how accurately the IRF-
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Figure 5. Analysis of IRF-dominant binding regions by principal component analysis (PCA) and machine learning. (A) PCA of IRF3-, IRF5- and IRF9-
dominant clusters based on IRF occupancy values (on the left) and 11 enhancer features (10 motif scores and ATAC-seq signal, on the right). Data points
representing individual peaks are colour-coded based on their original cluster labels. (B) A scheme showing the pair-wise comparisons for the Random
Forest method. (C) The accuracy of prediction by the Random Forest method using different sets of input variables. The scores for IRF-binding motifs,
motifs for co-activated TFs, ATAC-signals, and occurrence data concerning variants of ISRE and 6-mers, or all features were used as input variables for
the method. The number of features used for various Random Forest analyses is indicated. The accuracy indicates the percentage of correct predictions
(where the original and predicted cluster labels matched) relative to all predictions.
dominance could be predicted using different sets of fea-
tures. We performed pairwise comparisons (Figure 5B), us-
ing the cluster label (e.g. IRF3-, IRF5-, or IRF9-dominant)
of each binding region as ‘class label’. The motif scores
for ten PWMs, ATAC-signals, and occurrence data con-
cerning 37 variants of ISRE and 30 selected 6-mers were
used as attributes of the binding regions (Supplementary
Table S7). The accuracy of the prediction was calculated
based on the ratio of correct vs. all predictions. A pre-
diction was correct, when original and predicted class la-
bels agreed. We found that prediction accuracy was higher
when more features were included for the prediction (Fig-
ure 5C). The class labels were predicted with high accuracy
(>80%) when the IRF5-dominant cluster was compared
to the other two dominant clusters. The class label predic-
tion was less accurate (∼70%) for the comparison between
IRF3-dominant and IRF9-dominant clusters. The results
of the two methods confirmed each other; they indicated
that the IRF5-dominant cluster differed markedly from the
other two clusters. Based on the enhancer features, IRF3-
and IRF9-dominant clusters were less separated from each
other.
Genes encoding antiviral cytokines, inflammatory genes, and
antiviral ISGs in DCs are often associated with IRF3-, IRF5-
and IRF9-dominant regions
To investigate the biological relevance of the IRF3-, IRF5-,
and IRF9-dominant clusters, we examined the genomic
landscapes of three gene-sets: (i) antiviral cytokines, (ii) cy-
tokines and TFs of the inflammatory program and (iii) an-
tiviral ISGs.Many genes in these sets have been identified as
targets of IRF3, IRF5 and IRF9, respectively (1,12–14, 21).
We compiled three gene sets based on Gene Ontology (GO)
annotations and review articles (Supplementary Table S3).
The gene lists for antiviral cytokines, inflammatory pro-
gram, and antiviral ISGs contained 25, 119 and 63 genes,
respectively (Figure 6A, B and Supplementary Table S3).
Binding regions were determined and counted separately
for each gene in the 20-kb regions around the transcription
start sites (TSS± 10 kb).We found that in the 20-kbwindow
of antiviral cytokines, the IRF3-dominant cluster was espe-
cially enriched (Figure 6B). In the 20-kb window of genes
involved in the inflammatory program, the IRF5-dominant
and ‘IRF3 and IRF5’ clusters were over-represented, while
in the TSS ± 10 kb window of antiviral ISGs, the IRF9-
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Figure 6. Relationship between IRF binding regions and transcriptional programs. (A) A scheme showing the steps for the enrichment analysis. (B) The
enrichment of IRF-binding clusters in 20-kb regions around the transcription start site (TSS) of the genes belonging to three transcriptional programs. (C)
Radar graphs showing the median of values for seven features in IRF3- (red), IRF5- (blue), and IRF9-dominant (green) binding regions. The values were
calculated from the entire clusters (left) or from the peaks in 20-kb regions around the TSS of the genes belonging to the three transcriptional programs
(right). (D) The most characteristic patterns of the IRF3-, IRF5- and IRF9-dominant binding regions associated with the three gene sets. The symbols
indicate the ratios of the score of the given motif or ATAC-seq signal relative to the median of the unified IRF3/IRF5/IRF9 cistrome: ratio less than 0.8
(–), between 0.8 and 1.25 (≈), between 1.25 and 2 (+), and higher than 2 (++). (E) The genome browser view of the binding of IRF3, IRF5 and IRF9.
Three genes (TSS ±10kb) are shown for antiviral cytokines (top), inflammatory program (middle), and antiviral ISGs (bottom). (F) Induction kinetics of
the same genes were determined by qPCR in the DC line stimulated with pIC, CpG and IFN-. Expression was normalized relative to Rplp0. Mean and
SD of three independent experiments are shown.
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dominant and the ‘IRF3 and IRF9’ clusters occurred most
frequently (Figure 6B).
We also analysed the pattern of enhancer features for 28
IRF3-, 62 IRF5- and 45 IRF9-dominant binding regions,
which were localized in the TSS± 10 kbwindow of antiviral
cytokines, inflammatory genes, and antiviral ISGs, respec-
tively (Figure 6C). The analysis revealed that IRF-specific
binding regions associated with specific gene-sets (Figure
6C, right panel) had patterns similar to the entire cluster in
most cases (Figure 6C, left panel) with respect to the follow-
ing seven key features: ISRE, TISRE, NFKB, TRE, CRE,
GAS and ATAC-signal (Figure 6D).
Finally, based on their biological significance, we selected
genes, which were associated with IRF3, IRF5- or IRF9-
dominant peaks in their promoter regions (TSS ± 1 kb;
Figure 6E and Supplementary Figure S5A). Using qPCR,
we investigated whether they were induced most efficiently
by ligands and pathways that favoured the corresponding
IRFs. We found that selected antiviral cytokines, inflam-
matory genes, and antiviral ISGs were regulated most ef-
ficiently by pIC, CpG and IFN-, respectively (Figure 6F).
Because genes could be regulated by several enhancers and
signalling pathways could activate several TFs simultane-
ously, the dominance of the given pathway is not necessarily
mediated dominantly or exclusively by these regions and/or
these IRFs. However, in many cases their contribution was
certain. For example, in the case of antiviral ISGs, their TSS
± 10 kb window contained very few other enhancers (Fig-
ure 6E). Collectively, our results suggest that the identified
and characterized regions, which were occupied by predom-
inantly IRF3, IRF5 or IRF9, are important sites for signal
specific transcriptional responses.
To investigate the interactions (competitions and co-
operations) between IRFs or signaling pathways in our
system, we performed a series of ChIP-qPCR experiments
(Supplementary Figure S5B). In these experiments, theDCs
were stimulated with either single agonists or a combina-
tion of ligands. We found that IRF3 binding to the IRF3-
dominant regions of antiviral cytokines was inhibited by
all combined treatments. The IRF5 binding to the IRF5-
dominant regions of inflammatory genes was increased
when the pIC + CpG combination was used. However, in
other combinations, the IRF5 binding was inhibited. Be-
cause IRF5 was activated by both TLR3 and TLR9 ag-
onists (Supplementary Figure S5B), the increased IRF5
binding may be caused by cooperation between the two
pathways for IRF5 activation, and not by interaction be-
tween IRF3 and IRF5. Finally, the binding of IRF9 to
IRF9-dominant regions of antiviral ISGs was similar when
IFN- was used alone or in combination with CPG, sug-
gesting that the TLR9 pathway cannot inhibit IRF9 acti-
vation or binding. In all other ligand combinations, IRF9
binding was inhibited. Collectively, these results suggest
that competition/cooperation between IRFs (and/or other
TFs) and cross-talk between signalling pathways markedly
influence the binding of IRF3, IRF5 and IRF9.
DISCUSSION
IRF3, IRF5 and IRF9 play distinct but partially overlap-
ping roles in the regulation of antiviral cytokines, inflam-
matory responses, and cell-intrinsic antiviral immunity. The
first premise for this ‘division of labour’ is that IRFs dif-
fer from each other in their DNA-binding domain (DBD)
and IRF-association domains (IADs), which are responsi-
ble for interactions with other TFs (3). The second premise
is that cis-regulatory elements of IRF-regulated genes con-
tain features that differentially affect IRF binding. Recent
high-throughput studies have highlighted the features be-
yond primary DNA sequence motifs that modulate bind-
ing specificity (81). The same TF and external stimulus
regulate overlapping but distinct sets of genes in different
cell types. For example, some NF-B target genes are in-
duced to a similar extent in both macrophages and B cells,
while many others are preferentially activated in one cell
type or the other (24). Similarly, responses induced by I-
IFN are cell type-dependent (77). These cell type-specific
responses are due to several phenomena, e.g. differentially
expressed receptors, differences in the signalling pathways
and in the repertoires of inducible enhancers (24,77). Our
study suggests that DNA motifs occupied directly by IRFs
and additional features (e.g. binding of co-activated TFs
and chromatin accessibility) are involved in mediating IRF-
specificity. Of note, the regions within IRF-dominant clus-
ters were diverse, and not all regions shared the ‘prototypic
pattern’ of features (Figure 6D). The diversity of the regions
and the fact that none of the features occurred exclusively in
the clusters indicate that a series of features in a combinato-
rial fashion, rather than exclusively highly polarized DNA
sequences, mediate IRF-specific binding.
In this study, we identified and compared the IRF3-,
IRF5-, and IRF9-dominant regions. From the three clus-
ters, the IRF5-dominant cluster fundamentally differed
from the IRF3- and IRF9-dominant clusters. IRF5 could
occupy genomic loci via three potential mechanisms: (i)
binding as a homo- or heterodimer to ISREs, (ii) binding
as a monomer and (iii) indirect binding. The fact that ISRE
motif was enriched in the ‘IRF3 and IRF5’ and Common
clusters (Supplementary Figure S2D) suggests that at least a
subset of IRF5 proteins binds as dimers occupying canoni-
cal ISREs. The observations that an ISRE half-site (but not
ISRE) was identified by our de novo motif discovery in the
IRF5 cistrome (Supplementary Figure S2B) and the IRF5
logo from PBM study resembles a half-site logo with a sin-
gle core 5′-GAAA-3′ element (33) do not necessarily mean
that IRF5 binds dominantly or exclusively as monomers.
As suggested by Andrilenas et al. (33) the shorter logo rep-
resents a true dimer site but results from an IRF5 prefer-
ence to engagemore strongly to one ISRE half-site. In other
words, in PBMs, IRF5 binds as a dimer with an asymmetric
half-site preference (33). The last mechanism suggests that
IRF5 does not bind DNA directly, and its binding site is
determined by other TF(s). This has been shown for IRF3,
which can function as a signal-specific cofactor to activate
the transcription of a set of NF-B-dependent genes, with-
out binding to an ISRE (1,82). The contribution of indirect
binding for IRF5-mediated gene regulation awaits further
experimental confirmation.
We found that IRF5-dominant cluster had three char-
acteristic features. First, most of the IRF5-dominant re-
gions do not contain ISRE motifs. A recent study demon-
strated that bases other than C at the 5′ and 3′ positions rel-
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ative to the half-site (5′-CGAAAC-3′) could prevent IRF5
binding to the virus response elements of IFN promot-
ers (33). Our analysis revealed that not only ISRE vari-
ants, which contained bases other than C at these positions
(e.g. GAAANGGAAA), but all ISRE variants were un-
derrepresented in the IRF5-dominant cluster (Figure 3C).
Second, special ISRE half-sites, such as 5′-GAGA-3′ and
5′-GACA-3′, were enriched in the cluster. Further studies
are needed to reveal the premise and molecular mechanism
by which IRF5 binds to special 6-mers and whether IRF5
proteins could bind these ISRE half-sites as monomers.
Last, the high frequency of the NFKB motif in the IRF5-
dominant cluster was consistent with the observation that
IRF5 binding appears to rely in large part on its interactions
with NF-B (28).
IRF3- and IRF9-dominant regions were more similar to
each other, and the IRF3 versus IRF9 dominance was less
predictable (Figure 5C). There are several potential reasons
for the lower accuracy in prediction by machine learning.
Clustering itself may be inaccurate due to differences in
ChIP efficiency or other reasons. Certain non-characterized
features may also be required for accurate predictions. Such
‘missing features’ may include the number of motifs in a
given region, the distance between the different types ofmo-
tifs, the occupancy values of TFs, the presence of additional
motifs, or other variants of ISRE and 6-mers. A more com-
plex analysis in the future may reveal other features that are
needed for more accurate predictions. However, we uncov-
ered patterns, which favour either IRF3-dominant or IRF9-
dominant binding (Figures 2 and 6C).
In the IRF3-dominant cluster, we found that many of the
binding regions had low accessibility prior to stimulation.
The presence of higher frequencyNFKB,AICE (whichmay
serve as the binding site for IRF and AP-1), TRE and CRE
motifs in the cluster suggests that IRF3 requires the col-
laborative binding of other co-activated TFs to ‘open’ the
chromatin. Alternatively, tandem binding of three or four
IRF3 or other IRF(s) to TISRE, which are also enriched in
the cluster, may be sufficient for nucleosome removal. The
IRF3-dominant binding regions are not bound by IRF9
with high affinity, most likely because NF-B and AP-1 are
not induced in the I-IFN pathway.
We found that many IRF9-dominant regions contain
both ISRE and GAS motifs, without other motifs (Sup-
plementary Figure S4B). Although the consensus sequence
of 5′-WBVGGAAANNGAAACT-3′ (32) and its variants
were enriched in the IRF9-dominant cluster, their frequen-
cies were low (Supplementary Figure S3B). However, the
enrichment of the GAS motif (Figure 2D, E) suggests that
the STAT1 homodimers activated by I-IFN signalling are
important determinants for IRF9-dominant binding.
Collectively, this research highlights the need for inte-
grated analysis of in vitro and in vivo binding data, as well as
computational analysis to understand specific enhancer se-
lection bymembers of IRFs or other TF families. This study
contributes to our understanding of how IRFmembers can
initiate tailored responses to viral particles, inflammatory
agents, and type I interferons without activating superflu-
ous or harmful transcriptional programs in cells.
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